Mukund Paravasthu, Chief Operating Officer at NovoCure Ltd (NVCR), sold 44 shares at $16.69 ($734) on 2024-11-02, disclosed to the SEC on 2024-11-06.
Open-market sale of $734 NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2025-05-05 | $11K | — | Filing → |
| NVCR | SELL | 2025-03-04 | $5K | — | Filing → |
| NVCR | SELL | 2025-03-03 | $40K | — | Filing → |